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profile and lipodystrophy (Kotler, 2008) . Even though HAART has been utilized to reduce mortality and morbidity, there was an increase rate of death due to non-AIDS related illnesses or due to non-communicable diseases such as liver disease, lung cancer, renal impairment, cognitive impairment, osteoporosis and non-AIDS malignancies (Cardoso et al., 2013) .
Treatment and care for HIV patient may be complicated due to the prevalence of co-morbidities and non-communicable diseases. Furthermore, co-administration of multiple drugs in addition to HAART may lead to increase pill burden, potential drug-drug interaction and adverse effect, and loss of treatment efficacy and virological breakthrough (Nachega et al., 2012) .
The HIV and Aging Consensus Project initiated by the American Academy of HIV Medicine, which has created a clinical management for practitioners purposely for aging population with HIV. This guideline supported by American Geriatrics Society (AGS) and other organization is to guide the practitioners on managing ageing people with co-morbidities and HIV infection. Ministry of Health of Malaysia has developed a Guideline for the Management of Adult HIV with antiretroviral therapy. However, this guideline was lack of information about specific management for ageing people living with HIV.
Ministry of Health of Malaysia also has prepared the National Strategic Plan (NSP) on HIV/AIDS 2006-2010. This plan provided an integrated approach in order to identify the needs and support which involve multi-sectoral engagement to deliver the healthcare services and ARV treatment. Some of the strategies used were multi-sectoral engagement in HIV response; ARV treatment, resource mobilization; harm reduction program; mother-to-child transmission prevention; mobilization of the most at risk population; engagement with religious leaders and improvement to provide a quality information and report regarding HIV epidemic (Ministry of Health Malaysia, 2011). 
CONCLUSIONS
When HIV was first discovered in 1980s, the prognosis of the patients infected was very poor. With the advancement of treatment, the high hopes of the infected individuals for longer life expectancy and better quality of life can be achieved. Nevertheless, Ministry of Health of Malaysia and private sector stakeholders has to continuously provide medication and healthcare support in order to improve quality of life and treatment outcomes of ageing PLHIV.
